• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Pharmacy-dispensed drugs for secondary prevention after myocardial infarction.
Abstract BACKGROUND: Secondary prophylactic drugs are important for avoiding further cardiovascular events after myocardial infarction. We have examined whether patients collect these drugs from pharmacies and whether there are differences in survival between those who collect versus do not collect the drugs. MATERIAL AND METHOD: All patients <80 years registered in the Norwegian Myocardial Infarction Registry in 2013-16 were included in the study. The Norwegian Prescription Database was used to determine whether patients collected their prescriptions from pharmacies. RESULTS: During the study period,...
Source: Tidsskrift for den Norske Laegeforening - March 16, 2020 Category: General Medicine Authors: Jortveit J, Halvorsen S, Langørgen J Tags: Tidsskr Nor Laegeforen Source Type: research

Ti årsprediksjon av hjerte- og karsykdom hos friske norske menn basert på NORRISK-2.
Tiårsprediksjon av hjerte- og karsykdom hos friske norske menn basert på NORRISK-2. Tidsskr Nor Laegeforen. 2020 Sep 08;140(12): Authors: Mirza Y, Prestgaard EE, Selmer R, Liestøl K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K Abstract BACKGROUND: Norwegian guidelines for primary prevention of cardiovascular disease recommend the use of the NORRISK-2 risk model, with some additions. We wished to investigate whether NORRISK-2 could predict cardiovascular disease in healthy Norwegian men who took part in the Oslo Ischaemia Study. MATERIAL: NORRISK-2 scores were calculated for 2 014 men in ...
Source: Tidsskrift for den Norske Laegeforening - September 7, 2020 Category: General Medicine Authors: Mirza Y, Prestgaard EE, Selmer R, Liestøl K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K Tags: Tidsskr Nor Laegeforen Source Type: research

Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway
Purpose The ‘Outcomes & Multi-morbidity in Type 2 Diabetes’ (OMIT) is an observational registry-based cohort of Norwegian patients with type 2 diabetes (T2D) established to study high-risk groups often omitted from randomised clinical trials. Participants The OMIT cohort includes 57 572 patients with T2D identified via linkage of Norwegian Diabetes Register for Adults and the Rogaland-Oslo-Salten-Akershus-Hordaland study, both offering data on clinical patient characteristics and drug prescriptions. Subsequently these data are further linked to the Norwegian Prescription Database for dispensed medications,...
Source: BMJ Open - May 11, 2022 Category: General Medicine Authors: Forster, R. B., Strandberg, R. B., Bo Tibballs, K. L., Nokleby, K., Berg, T. J., Iversen, T., Hagen, T. P., Richardsen, K. R., Cooper, J., Sandberg, S., Lovaas, K. F., Nilsen, R. M., Iversen, M. M., Jenum, A. K., Buhl, E. S. S. Tags: Open access, Diabetes and Endocrinology Source Type: research

Experiences and actions related to living with type 1 diabetes during the COVID-19 pandemic in Norway: a qualitative study conducted during July to December 2020
Conclusions Patients experienced an increased psychosocial burden of T1DM and difficulties from a disrupted daily life affecting T1DM self-management routines. Uncertainty-reducing behaviours and actions to adapt to the situation provided a general sense of coping despite these difficulties. Tailored information and follow-up by telephone or video call was emphasised to reduce uncertainly distress and support adequate diabetes T1DM self-management.
Source: BMJ Open - April 7, 2022 Category: General Medicine Authors: Pleym, K., Iversen, M. M., Broström, A. Tags: Open access, Diabetes and Endocrinology, COVID-19 Source Type: research

Pages: 1  2